Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26014293

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Sep 1
First author
Andtbacka RH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Aug;12(8):438. doi: 10.1038/nrclinonc.2015.106.
    note
    Source null
    related pmid
    26077044
    relationship
    Comment in
  2. citation
    Ann Surg Oncol. 2016 Dec;23(13):4126-4129. doi: 10.1245/s10434-016-5393-y.
    note
    Source null
    related pmid
    27380046
    relationship
    Comment in
  3. citation
    Nature. 2018 May;557(7704):150-151. doi: 10.1038/d41586-018-05104-1.
    note
    Source null
    related pmid
    29740143
    relationship
    Comment in

Authors and identifiers

  1. name
    Andtbacka RH
    type
    Author
  2. name
    Kaufman HL
    type
    Author
  3. name
    Collichio F
    type
    Author
  4. name
    Amatruda T
    type
    Author
  5. name
    Senzer N
    type
    Author
  6. name
    Chesney J
    type
    Author
  7. name
    Delman KA
    type
    Author
  8. name
    Spitler LE
    type
    Author
  9. name
    Puzanov I
    type
    Author
  10. name
    Agarwala SS
    type
    Author
  11. name
    Milhem M
    type
    Author
  12. name
    Cranmer L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Andtbacka RH
    type
    Author
  2. name
    Kaufman HL
    type
    Author
  3. name
    Collichio F
    type
    Author
  4. name
    Amatruda T
    type
    Author
  5. name
    Senzer N
    type
    Author
  6. name
    Chesney J
    type
    Author
  7. name
    Delman KA
    type
    Author
  8. name
    Spitler LE
    type
    Author
  9. name
    Puzanov I
    type
    Author
  10. name
    Agarwala SS
    type
    Author
  11. name
    Milhem M
    type
    Author
  12. name
    Cranmer L
    type
    Author
bibliography ids
  1. nci-bib-2c17999f4c94e4044bd55caf
book metadata
content sha256
44710e3cdcd3b1940ddcb05b1640c91348e7d6fb02708359de8912d00fbfbfc4
document type
citation
dois
  1. 10.1200/JCO.2014.58.3377
electronic publication date
display
2015 May 26
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26014293
immutable id
pubmed:26014293@44710e3cdcd3b1940ddcb05b1640c91348e7d6fb02708359de8912d00fbfbfc4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
25
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2780-8
volume
33
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2015 Aug;12(8):438. doi: 10.1038/nrclinonc.2015.106.
    note
    Source null
    related pmid
    26077044
    relationship
    Comment in
  2. citation
    Ann Surg Oncol. 2016 Dec;23(13):4126-4129. doi: 10.1245/s10434-016-5393-y.
    note
    Source null
    related pmid
    27380046
    relationship
    Comment in
  3. citation
    Nature. 2018 May;557(7704):150-151. doi: 10.1038/d41586-018-05104-1.
    note
    Source null
    related pmid
    29740143
    relationship
    Comment in
outcomes validated
false
pmid
26014293
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
7185ba5ad86805eecbce02af07d2f7cc0885de733712ed4e25e67bb575ecd8f4
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Sep 1
precision
day
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26014293/
title
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

Preserved source evidence · Not medical advice